Search Within

George Bosl

Formats
  1. Journal Article (318)
  2. Meeting Abstract (80)
  3. Book Section (19)
  4. Conference Paper (11)
  5. Editorial (2)
  6. Correspondence (1)
  7. Miscellaneous (1)
Groups
  1. Survivorship Research (432)
  2. Department of Medicine (286)
  3. Solid Tumor Oncology Division (283)
  4. Genitourinary Oncology Service (250)
  5. Surgery (164)
  6. Urology (137)

More Groups

People
  1. Robert Motzer (182)
  2. Dean Bajorin (147)
  3. Joel Sheinfeld (110)
  4. Victor Reuter (99)
  5. Raju Chaganti (92)
  6. Darren Feldman (86)

More People

Years
  1. 2025 (3)
  2. 2024 (1)
  3. 2023 (1)
  4. 2022 (1)
  5. 2021 (4)
  6. 2020 (4)

More Years

Publications
  1. Journal of Clinical Oncology (121)
  2. Cancer (28)
  3. Cancer Research (22)
  4. Journal of Urology (19)
  5. Urology (16)
  6. Proceedings of the American Association for Cancer Research Annual Meeting (13)

More Publications

Publishers
  1. American Society of Clinical Oncology (126)
  2. Elsevier Science, Inc. (48)
  3. American Association for Cancer Research (39)
  4. Wiley Blackwell (37)
  5. Elsevier Inc. (27)
  6. Springer (17)

More Publishers

Results (432)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Active cancer therapy combining 13-cis-retinoic acid with interferon-α
    Journal Article

    Dmitrovsky, E.; Bosl, G. J.
    JNCI: Journal of the National Cancer Institute (1992)

    Fulltext@MSK | Save
  • The late effects of germ cell tumor chemotherapy: More data are needed
    Journal Article

    Bosl, G. J.
    Journal of Clinical Oncology (1992)

    Fulltext@MSK | Save
  • Current status of larynx preservation with multimodality therapy
    Journal Article

    Pfister, D. G.; Harrison, L. B.; Strong, E. W.; Bosl, G. J.
    Oncology (Norwalk) (1992)

    Fulltext@MSK | Save
  • High-dose chemotherapy for resistant germ cell tumors: Recent advances and future directions
    Journal Article

    Motzer, R. J.; Bosl, G. J.
    JNCI: Journal of the National Cancer Institute (1992)

    Fulltext@MSK | Save
  • Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: The Memorial Sloan-Kettering Cancer Center experience
    Journal Article

    Motzer, R. J.; Bajorin, D. F.; Vlamis, V.; Weisen, S.; Bosl, G. J.
    Seminars in Oncology (1992)

    Fulltext@MSK | Save
  • Current perspectives on the role of adjunctive surgery in combined modality treatment for patients with germ cell tumors
    Journal Article

    Bajorin, D. F.; Herr, H.; Motzer, R. J.; Bosl, G. J.
    Seminars in Oncology (1992)

    Fulltext@MSK | Save
  • The genetic and biologic aspects of treatment response and resistance in male germ cell cancer
    Journal Article

    Kurie, J. M.; Bosl, G. J.; Dmitrovsky, E.
    Seminars in Oncology (1992)

    Fulltext@MSK | Save
  • Allelic deletions in the long arm of chromosome 12 identify sites of candidate tumor suppressor genes in male germ cell tumors
    Journal Article

    Murty, V. V. V. S.; Houldsworth, J.; Baldwin, S.; Reuter, V.; Hunziker, W.; Besmer, P.; Bosl, G.; Chaganti, R. S. K.
    Proceedings of the National Academy of Sciences of the United States of America (1992)

    Fulltext@MSK | Save
  • Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors
    Journal Article

    Wood, D. P. Jr; Herr, H. W.; Heller, G.; Vlamis, V.; Sogani, P. C.; Motzer, R. J.; Fair, W. R.; Bosl, G. J.
    Journal of Urology (1992)

    Fulltext@MSK | Save
  • A phase II trial of interleukin-2 and interferon Alfa-2a in patients with advanced renal cell carcinoma
    Journal Article

    Ilson, D. H.; Motzer, R. J.; Kradin, R. L.; Vogelzang, N. J.; Bajorin, D. F.; Scher, H. I.; Nanus, D.; O'Moore, P.; Marathias, K.; Bosl, G. J.
    Journal of Clinical Oncology (1992)

    Fulltext@MSK | Save